Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience.

Caudill, Jonathan S; Brown, Paul D; Cerhan, Jane H; Rummans, Teresa A

Caudill, Jonathan S; Brown, Paul D; Cerhan, Jane H; Rummans, Teresa A.

Affiliation

Caudill JS; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.

Am J Clin Oncol ; 34(4): 385-7, 2011 Aug.

Article in En | MEDLINE | ID: mdl-20859197

Subject(s)

Antidepressive Agents/therapeutic use; Brain Neoplasms/therapy; Depressive Disorder/drug therapy; Depressive Disorder/mortality; Glioblastoma/therapy; Selective Serotonin Reuptake Inhibitors/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms/complications; Brain Neoplasms/mortality; Child; Child, Preschool; Cohort Studies; Depressive Disorder/etiology; Female; Follow-Up Studies; Glioblastoma/complications; Glioblastoma/mortality; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Selective Serotonin Reuptake Inhibitors / Glioblastoma / Depressive Disorder / Antidepressive Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google